MYGN
Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients' lives through the discovery and commercialization of transformative tests to diagnose critical diseases. The company develops and markets novel predictive medicine, personalized medicine, and prognostic medicine tests.
No recent news for this company.